KCM
ORGO icon

Kennedy Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Kennedy Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-101,782
Closed -$330K – 635
2022
Q3 		$330K Sell
101,782
-10,487
-9% -$47.4K 0.01% 573
2022
Q2 		$548K Sell
112,269
-1,082
-1% -$6.66K 0.02% 535
2022
Q1 		$864K Sell
113,351
-17,594
-13% -$136K 0.02% 514
2021
Q4 		$1.21M Buy
+130,945
New +$1.39M 0.03% 494

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Kennedy Capital Management's ORGO Position: Q4 2022 in Review

Kennedy Capital Management sold out of Organogenesis Holdings (ORGO) in Q4 2022, closing a stake of 101,782 shares — an estimated $330K sold.

Kennedy Capital Management first reported a position in ORGO in Q4 2021 and held it in 4 quarters. The position peaked at $1.21M in Q4 2021. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Kennedy Capital Management reported no remaining Organogenesis Holdings position as of Q4 2022 after selling out during the quarter.
  • Kennedy Capital Management sold 101,782 Organogenesis Holdings shares in Q4 2022, an estimated $330K.
  • Kennedy Capital Management first reported a position in Organogenesis Holdings in Q4 2021 and held it in 4 quarters.
  • Kennedy Capital Management's Organogenesis Holdings position peaked at $1.21M in Q4 2021.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Kennedy Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.